Skip to main content Accessibility help

Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders

  • Rúbia W. de Oliveira (a1), Cilene L. Oliveira (a2), Francisco S. Guimarães (a3) (a4) and Alline C. Campos (a3) (a4)


Cannabinoid signalling modulates several aspects of brain function, including the generation and survival of neurons during embryonic and adult periods. The present review intended to summarise evidence supporting a role for the endocannabinoid system on the control of neurogenesis and neurogenesis-dependent functions. Studies reporting participation of cannabinoids on the regulation of any step of neurogenesis and the effects of cannabinoid compounds on animal models possessing neurogenesis-dependent features were selected from Medline. Qualitative evaluation of the selected studies indicated that activation of cannabinoid receptors may change neurogenesis in embryonic or adult nervous systems alongside rescue of phenotypes in animal models of different psychiatric and neurological disorders. The text offers an overview on the effects of cannabinoids on central nervous system development and the possible links with psychiatric and neurological disorders such as anxiety, depression, schizophrenia, brain ischaemia/stroke and Alzheimer’s disease. An understanding of the mechanisms by which cannabinoid signalling influences developmental and adult neurogenesis will help foster the development of new therapeutic strategies for neurodevelopmental, psychiatric and neurological disorders.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders
      Available formats


Corresponding author

Author for correspondence: Dr. Rúbia W. de Oliveira, Laboratory of Neuropsychopharmacology, Department of Pharmacology and Therapeutics, State University of Maringá, Av. Colombo 5790, K-68, 104a, Maringá, Paraná 87020-900, Brazil. Tel: +55 44 30115165; Fax: +55 44 30114999; E-mail:


Hide All
1. Gage, FH, Kempermann, G, Palmer, TD, Peterson, DA Ray, J (1998) Multipotent progenitor cells in the adult dentate gyrus. J Neurobiol 36, 249266.
2. Lindsey, BW Tropepe, V (2006) A comparative framework for understanding the biological principles of adult neurogenesis. Prog Neurobiol 80, 281307.
3. Czaja, K, Fornaro, M Geuna, S (2012) Neurogenesis in the adult peripheral nervous system. Neural Regen Res 7, 10471054.
4. Altman, J Das, GD (1965) Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124, 319335.
5. Jordan, JD, Ma, DK, Ming, GL Song, H (2007) Cellular niches for endogenous neural stem cells in the adult brain. CNS Neurol Disord Drug Targets 6, 336341.
6. Ming, GL Song, H (2011) Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron 70, 687702.
7. Corotto, FS, Henegar, JA Maruniak, JA (1993) Neurogenesis persists in the subependymal layer of the adult mouse brain. Neurosci Lett 149, 111114.
8. Garcia-Verdugo, JM, Doetsch, F, Wichterle, H, Lim, DA Alvarez-Buylla, A (1998) Architecture and cell types of the adult subventricular zone: in search of the stem cells. J Neurobiol 36, 234248.
9. Eriksson, PS, Perfilieva, E, Bjork-Eriksson, T, Alborn, AM, Nordborg, C, Peterson, DA Gage, FH (1998) Neurogenesis in the adult human hippocampus. Nat Med 4, 13131317.
10. Kornack, DR Rakic, P (2001) The generation, migration, and differentiation of olfactory neurons in the adult primate brain. Proc Natl Acad Sci U S A 98, 47524757.
11. Spalding, KL, Bergmann, O, Alkass, K, Bernard, S, Salehpour, M, Huttner, HB, Bostrom, E, Westerlund, I, Vial, C, Buchholz, BA, Possnert, G, Mash, DC, Druid, H Frisen, J (2013) Dynamics of hippocampal neurogenesis in adult humans. Cell 153, 12191227.
12. Snyder, JS Cameron, HA (2012) Could adult hippocampal neurogenesis be relevant for human behavior? Behav Brain Res 227, 384390.
13. Ihunwo, AO, Tembo, LH Dzamalala, C (2016) The dynamics of adult neurogenesis in human hippocampus. Neural Regen Res 11, 18691883.
14. Bergami, M, Masserdotti, G, Temprana, SG, Motori, E, Eriksson, TM, Gobel, J, Yang, SM, Conzelmann, KK, Schinder, AF, Gotz, M Berninger, B (2015) A critical period for experience-dependent remodeling of adult-born neuron connectivity. Neuron 85, 710717.
15. Urban, N Guillemot, F (2014) Neurogenesis in the embryonic and adult brain: same regulators, different roles. Front Cell Neurosci 8, 396.
16. Jessberger, S, Toni, N, Clemenson, GD Jr., Ray, J Gage, FH (2008) Directed differentiation of hippocampal stem/progenitor cells in the adult brain. Nat Neurosci 11, 888893.
17. Carr, VM Farbman, AI (1993) The dynamics of cell death in the olfactory epithelium. Exp Neurol 124, 308314.
18. Almeida, OF, Conde, GL, Crochemore, C, Demeneix, BA, Fischer, D, Hassan, AH, Meyer, M, Holsboer, F Michaelidis, TM (2000) Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J 14, 779790.
19. Andersen, J, Urban, N, Achimastou, A, Ito, A, Simic, M, Ullom, K, Martynoga, B, Lebel, M, Goritz, C, Frisen, J, Nakafuku, M Guillemot, F (2014) A transcriptional mechanism integrating inputs from extracellular signals to activate hippocampal stem cells. Neuron 83, 10851097.
20. Paridaen, JT Huttner, WB (2014) Neurogenesis during development of the vertebrate central nervous system. EMBO Rep 15, 351364.
21. Bond, AM, Ming, GL Song, H (2015) Adult mammalian neural stem cells and neurogenesis: five decades later. Cell Stem Cell 17, 385395.
22. Guan, K, Chang, H, Rolletschek, A Wobus, AM (2001) Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res 305, 171176.
23. Gotz, M Huttner, WB (2005) The cell biology of neurogenesis. Nat Rev Mol Cell Biol 6, 777788.
24. Qian, X, Shen, Q, Goderie, SK, He, W, Capela, A, Davis, AA Temple, S (2000) Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron 28, 6980.
25. Alvarez-Buylla, A (1990) Mechanism of neurogenesis in adult avian brain. Experientia 46, 948955.
26. Cayre, M, Canoll, P Goldman, JE (2009) Cell migration in the normal and pathological postnatal mammalian brain. Prog Neurobiol 88, 4163.
27. Lois, C Alvarez-Buylla, A (1994) Long-distance neuronal migration in the adult mammalian brain. Science 264, 11451148.
28. Cameron, HA, Woolley, CS, McEwen, BS Gould, E (1993) Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience 56, 337344.
29. Cipriani, S, Nardelli, J, Verney, C, Delezoide, AL, Guimiot, F, Gressens, P Adle-Biassette, H (2016) Dynamic expression patterns of progenitor and pyramidal neuron layer markers in the developing human hippocampus. Cereb Cortex 26, 12551271.
30. Pencea, V, Bingaman, KD, Freedman, LJ Luskin, MB (2001) Neurogenesis in the subventricular zone and rostral migratory stream of the neonatal and adult primate forebrain. Exp Neurol 172, 116.
31. Peretto, P, Merighi, A, Fasolo, A Bonfanti, L (1997) Glial tubes in the rostral migratory stream of the adult rat. Brain Res Bull 42, 921.
32. Sawamoto, K, Wichterle, H, Gonzalez-Perez, O, Cholfin, JA, Yamada, M, Spassky, N, Murcia, NS, Garcia-Verdugo, JM, Marin, O, Rubenstein, JL, Tessier-Lavigne, M, Okano, H Alvarez-Buylla, A (2006) New neurons follow the flow of cerebrospinal fluid in the adult brain. Science 311, 629632.
33. Alvarez-Buylla, A Garcia-Verdugo, JM (2002) Neurogenesis in adult subventricular zone. J Neurosci 22, 629634.
34. Kintner, C (2002) Neurogenesis in embryos and in adult neural stem cells. J Neurosci 22, 639643.
35. Jagasia, R, Song, H, Gage, FH Lie, DC (2006) New regulators in adult neurogenesis and their potential role for repair. Trends Mol Med 12, 400405.
36. Pathania, M, Yan, LD Bordey, A (2010) A symphony of signals conducts early and late stages of adult neurogenesis. Neuropharmacology 58, 865876.
37. Hagg, T (2005) Molecular regulation of adult CNS neurogenesis: an integrated view. Trends Neurosci 28, 589595.
38. Katona, I, Urban, GM, Wallace, M, Ledent, C, Jung, KM, Piomelli, D, Mackie, K Freund, TF (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26, 56285637.
39. Harkany, T, Keimpema, E, Barabas, K Mulder, J (2008) Endocannabinoid functions controlling neuronal specification during brain development. Mol Cell Endocrinol 286, S84S90.
40. Pertwee, RG (2005) Pharmacological actions of cannabinoids. Handb Exp Pharmacol 168, 151.
41. Mechoulam, R Gaoni, Y (1965) A total synthesis of dl-delta-1-tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87, 32733275.
42. Turner, SE, Williams, CM, Iversen, L Whalley, BJ (2017) Molecular pharmacology of phytocannabinoids. Prog Chem Org Nat Prod 103, 61101.
43. Devane, WA, Dysarz, FA 3rd, Johnson, MR, Melvin, LS Howlett, AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34, 605613.
44. Matsuda, LA, Lolait, SJ, Brownstein, MJ, Young, AC Bonner, TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561564.
45. Munro, S, Thomas, KL Abu-Shaar, M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 6165.
46. Szabo, B Schlicker, E (2005) Effects of cannabinoids on neurotransmission. Handb Exp Pharmacol 168, 327365.
47. Tsou, K, Mackie, K, Sanudo-Pena, MC Walker, JM (1999) Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 93, 969975.
48. Wilson, RI Nicoll, RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588592.
49. Takahashi, KA Castillo, PE (2006) The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 139, 795802.
50. Lau, T Schloss, P (2008) The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons. Eur J Pharmacol 578, 137141.
51. Yoshida, T, Hashimoto, K, Zimmer, A, Maejima, T, Araishi, K Kano, M (2002) The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J Neurosci 22, 16901697.
52. Diana, MA Marty, A (2004) Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol 142, 919.
53. Marsicano, G, Goodenough, S, Monory, K, Hermann, H, Eder, M, Cannich, A, Azad, SC, Cascio, MG, Gutierrez, SO, van der Stelt, M, Lopez-Rodriguez, ML, Casanova, E, Schutz, G, Zieglgansberger, W, Di Marzo, V, Behl, C Lutz, B (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 8488.
54. Fogaca, MV, Galve-Roperh, I, Guimaraes, FS Campos, AC (2013) Cannabinoids, neurogenesis and antidepressant drugs: Is there a link? Curr Neuropharmacol 11, 263275.
55. Onaivi, ES, Ishiguro, H, Gong, JP, Patel, S, Perchuk, A, Meozzi, PA, Myers, L, Mora, Z, Tagliaferro, P, Gardner, E, Brusco, A, Akinshola, BE, Liu, QR, Hope, B, Iwasaki, S, Arinami, T, Teasenfitz, L Uhl, GR (2006) Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 1074, 514536.
56. Palazuelos, J, Aguado, T, Egia, A, Mechoulam, R, Guzman, M Galve-Roperh, I (2006) Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J 20, 24052407.
57. Lisboa, SF, Gomes, FV, Guimaraes, FS Campos, AC (2016) Microglial cells as a link between cannabinoids and the immune hypothesis of psychiatric disorders. Front Neurol 7, 5.
58. Xi, ZX, Peng, XQ, Li, X, Song, R, Zhang, HY, Liu, QR, Yang, HJ, Bi, GH, Li, J Gardner, EL (2011) Brain cannabinoid CB(2) receptors modulate cocaine’s actions in mice. Nat Neurosci 14, 11601166.
59. Devane, WA, Hanus, L, Breuer, A, Pertwee, RG, Stevenson, LA, Griffin, G, Gibson, D, Mandelbaum, A, Etinger, A Mechoulam, R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 19461949.
60. Mechoulam, R, Ben-Shabat, S, Hanus, L, Ligumsky, M, Kaminski, NE, Schatz, AR, Gopher, A, Almog, S, Martin, BR, Compton, DR, Pertwee, RG, Griffin, G, Bayewitch, M, Barg, J Vogel, Z (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83--90.
61. Saito, VM, Wotjak, CT Moreira, FA (2010) Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders? Rev Bras Psiquiatr 32(Suppl. 1):S7S14.
62. Campos, AC, Paraíso-Luna, J, Fogaça, MV, Guimarães, FS Galve-Roperh, I (2017) Cannabinoids as regulators of neural development and adult neurogenesis. Lipidomics of Stem Cells 6, 117136.
63. Aguado, T, Monory, K, Palazuelos, J, Stella, N, Cravatt, B, Lutz, B, Marsicano, G, Kokaia, Z, Guzman, M Galve-Roperh, I (2005) The endocannabinoid system drives neural progenitor proliferation. FASEB J 19, 17041706.
64. Aguado, T, Palazuelos, J, Monory, K, Stella, N, Cravatt, B, Lutz, B, Marsicano, G, Kokaia, Z, Guzman, M Galve-Roperh, I (2006) The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J Neurosci 26, 15511561.
65. Diaz-Alonso, J, Guzman, M Galve-Roperh, I (2012) Endocannabinoids via CB(1) receptors act as neurogenic niche cues during cortical development. Philos Trans R Soc Lond B Biol Sci 367, 32293241.
66. Diaz-Alonso, J, Aguado, T, de Salas-Quiroga, A, Ortega, Z, Guzman, M Galve-Roperh, I (2015) CB1 Cannabinoid receptor-dependent activation of mTORC1/Pax6 signaling drives Tbr2 expression and basal progenitor expansion in the developing mouse cortex. Cereb Cortex 25, 23952408.
67. Maccarrone, M, Guzman, M, Mackie, K, Doherty, P Harkany, T (2014) Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nat Rev Neurosci 15, 786801.
68. Keimpema, E, Tortoriello, G, Alpar, A, Capsoni, S, Arisi, I, Calvigioni, D, Hu, SS, Cattaneo, A, Doherty, P, Mackie, K Harkany, T (2013) Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons. Proc Natl Acad Sci U S A 110, 19351940.
69. Maison, P, Walker, DJ, Walsh, FS, Williams, G Doherty, P (2009) BDNF regulates neuronal sensitivity to endocannabinoids. Neurosci Lett 467, 9094.
70. Keimpema, E, Alpar, A, Howell, F, Malenczyk, K, Hobbs, C, Hurd, YL, Watanabe, M, Sakimura, K, Kano, M, Doherty, P Harkany, T (2013) Diacylglycerol lipase alpha manipulation reveals developmental roles for intercellular endocannabinoid signaling. Sci Rep 3, 2093.
71. Harkany, T, Guzman, M, Galve-Roperh, I, Berghuis, P, Devi, LA Mackie, K (2007) The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci 28, 8392.
72. Oudin, MJ, Hobbs, C Doherty, P (2011) DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis. Eur J Neurosci 34, 16341646.
73. Goncalves, MB, Suetterlin, P, Yip, P, Molina-Holgado, F, Walker, DJ, Oudin, MJ, Zentar, MP, Pollard, S, Yanez-Munoz, RJ, Williams, G, Walsh, FS, Pangalos, MN Doherty, P (2008) A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol Cell Neurosci 38, 526536.
74. Campos, AC, Ortega, Z, Palazuelos, J, Fogaca, MV, Aguiar, DC, Diaz-Alonso, J, Ortega-Gutierrez, S, Vazquez-Villa, H, Moreira, FA, Guzman, M, Galve-Roperh, I Guimaraes, FS (2013) The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. Int J Neuropsychopharmacol 16, 14071419.
75. Mato, S, Del Olmo, E Pazos, A (2003) Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci 17, 17471754.
76. Berrendero, F, Mendizabal, V, Murtra, P, Kieffer, BL Maldonado, R (2003) Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice. Eur J Neurosci 18, 21972202.
77. Zimmer, A, Zimmer, AM, Hohmann, AG, Herkenham, M Bonner, TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci U S A 96, 57805785.
78. Zurolo, E, Iyer, AM, Spliet, WG, Van Rijen, PC, Troost, D, Gorter, JA Aronica, E (2010) CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies. Neuroscience 170, 2841.
79. Mulder, J, Aguado, T, Keimpema, E, Barabas, K, Ballester Rosado, CJ, Nguyen, L, Monory, K, Marsicano, G, Di Marzo, V, Hurd, YL, Guillemot, F, Mackie, K, Lutz, B, Guzman, M, Lu, HC, Galve-Roperh, I Harkany, T (2008) Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci U S A 105, 87608765.
80. Bisogno, T, Howell, F, Williams, G, Minassi, A, Cascio, MG, Ligresti, A, Matias, I, Schiano-Moriello, A, Paul, P, Williams, EJ, Gangadharan, U, Hobbs, C, Di Marzo, V Doherty, P (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163, 463468.
81. Alpar, A, Tortoriello, G, Calvigioni, D, Niphakis, MJ, Milenkovic, I, Bakker, J, Cameron, GA, Hanics, J, Morris, CV, Fuzik, J, Kovacs, GG, Cravatt, BF, Parnavelas, JG, Andrews, WD, Hurd, YL, Keimpema, E Harkany, T (2014) Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. Nat Commun 5, 4421.
82. Berghuis, P, Dobszay, MB, Wang, X, Spano, S, Ledda, F, Sousa, KM, Schulte, G, Ernfors, P, Mackie, K, Paratcha, G, Hurd, YL Harkany, T (2005) Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc Natl Acad Sci U S A 102, 1911519120.
83. Roland, AB, Ricobaraza, A, Carrel, D, Jordan, BM, Rico, F, Simon, A, Humbert-Claude, M, Ferrier, J, McFadden, MH, Scheuring, S Lenkei, Z (2014) Cannabinoid-induced actomyosin contractility shapes neuronal morphology and growth. Elife 3, e03159.
84. Morozov, YM, Torii, M Rakic, P (2009) Origin, early commitment, migratory routes, and destination of cannabinoid type 1 receptor-containing interneurons. Cereb Cortex 19(Suppl. 1):i7889.
85. Palazuelos, J, Ortega, Z, Diaz-Alonso, J, Guzman, M Galve-Roperh, I (2012) CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling. J Biol Chem 287, 11981209.
86. Molina-Holgado, F, Rubio-Araiz, A, Garcia-Ovejero, D, Williams, RJ, Moore, JD, Arevalo-Martin, A, Gomez-Torres, O Molina-Holgado, E (2007) CB2 cannabinoid receptors promote mouse neural stem cell proliferation. Eur J Neurosci 25, 629634.
87. Prenderville, JA, Kelly, AM Downer, EJ (2015) The role of cannabinoids in adult neurogenesis. Br J Pharmacol 172, 39503963.
88. Hill, MN, Titterness, AK, Morrish, AC, Carrier, EJ, Lee, TT, Gil-Mohapel, J, Gorzalka, BB, Hillard, CJ Christie, BR (2010) Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. Hippocampus 20, 513523.
89. Gao, Y, Vasilyev, DV, Goncalves, MB, Howell, FV, Hobbs, C, Reisenberg, M, Shen, R, Zhang, MY, Strassle, BW, Lu, P, Mark, L, Piesla, MJ, Deng, K, Kouranova, EV, Ring, RH, Whiteside, GT, Bates, B, Walsh, FS, Williams, G, Pangalos, MN, Samad, TA Doherty, P (2010) Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 30, 20172024.
90. Jenniches, I, Ternes, S, Albayram, O, Otte, DM, Bach, K, Bindila, L, Michel, K, Lutz, B, Bilkei-Gorzo, A Zimmer, A (2016) Anxiety, stress, and fear response in mice with reduced endocannabinoid levels. Biol Psychiatry 79, 858868.
91. Wolf, SA, Bick-Sander, A, Fabel, K, Leal-Galicia, P, Tauber, S, Ramirez-Rodriguez, G, Muller, A, Melnik, A, Waltinger, TP, Ullrich, O Kempermann, G (2010) Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Cell Commun Signal 8, 12.
92. Campos, AC, Fogaca, MV, Scarante, FF, Joca, SRL, Sales, AJ, Gomes, FV, Sonego, AB, Rodrigues, NS, Galve-Roperh, I Guimaraes, FS (2017) Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders. Front Pharmacol 8, 269.
93. Jin, K, Xie, L, Kim, SH, Parmentier-Batteur, S, Sun, Y, Mao, XO, Childs, J Greenberg, DA (2004) Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol 66, 204208.
94. Lee, S, Kim, DH, Yoon, SH Ryu, JH (2009) Sub-chronic administration of rimonabant causes loss of antidepressive activity and decreases doublecortin immunoreactivity in the mouse hippocampus. Neurosci Lett 467, 111116.
95. Han, MH, Lee, EH Koh, SH (2016) Current opinion on the role of neurogenesis in the therapeutic strategies for Alzheimer disease, Parkinson disease, and ischemic stroke; considering neuronal voiding function. Int Neurourol J 20, 276287.
96. Mu, Y Gage, FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol Neurodegener 6, 85.
97. Martinez-Canabal, A (2014) Reconsidering hippocampal neurogenesis in Alzheimer’s disease. Front Neurosci 8, 147.
98. Iannitelli, A, Quartini, A, Tirassa, P Bersani, G (2017) Schizophrenia and neurogenesis: a stem cell approach. Neurosci Biobehav Rev 80, 414442.
99. Campos, AC, Moreira, FA, Gomes, FV, Del Bel, EA Guimaraes, FS (2012) Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci 367, 33643378.
100. Duman, RS, Malberg, J, Nakagawa, S D’Sa, C (2000) Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48, 732739.
101. Vivar, C (2015) Adult hippocampal neurogenesis, aging and neurodegenerative diseases: possible strategies to prevent cognitive impairment. Curr Top Med Chem 15, 21752192.
102. Kawai, T, Takagi, N, Miyake-Takagi, K, Okuyama, N, Mochizuki, N Takeo, S (2004) Characterization of BrdU-positive neurons induced by transient global ischemia in adult hippocampus. J Cereb Blood Flow Metab 24, 548555.
103. Parent, JM (2003) Injury-induced neurogenesis in the adult mammalian brain. Neuroscientist 9, 261272.
104. Liu, YW, Curtis, MA, Gibbons, HM, Mee, EW, Bergin, PS, Teoh, HH, Connor, B, Dragunow, M Faull, RL (2008) Doublecortin expression in the normal and epileptic adult human brain. Eur J Neurosci 28, 22542265.
105. Hollands, C, Bartolotti, N Lazarov, O (2016) Alzheimer’s disease and hippocampal adult neurogenesis; exploring shared mechanisms. Front Neurosci 10, 178.
106. Regensburger, M, Prots, I Winner, B (2014) Adult hippocampal neurogenesis in Parkinson’s disease: impact on neuronal survival and plasticity. Neural Plast 2014, 454696.
107. Kempermann, G Kronenberg, G (2003) Depressed new neurons--adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol Psychiatry 54, 499503.
108. David, DJ, Wang, J, Samuels, BA, Rainer, Q, David, I, Gardier, AM Hen, R (2010) Implications of the functional integration of adult-born hippocampal neurons in anxiety-depression disorders. Neuroscientist 16, 578591.
109. Christian, KM, Song, H Ming, GL (2014) Functions and dysfunctions of adult hippocampal neurogenesis. Annu Rev Neurosci 37, 243262.
110. Kang, E, Wen, Z, Song, H, Christian, KM Ming, GL (2016) Adult neurogenesis and psychiatric disorders. Cold Spring Harb Perspect Biol 8, 9.
111. Yun, S, Reynolds, RP, Masiulis, I Eisch, AJ (2016) Re-evaluating the link between neuropsychiatric disorders and dysregulated adult neurogenesis. Nat Med 22, 12391247.
112. Sheline, YI (1996) Hippocampal atrophy in major depression: a result of depression-induced neurotoxicity? Mol Psychiatry 1, 298299.
113. Kitayama, N, Vaccarino, V, Kutner, M, Weiss, P Bremner, JD (2005) Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis. J Affect Disord 88, 7986.
114. Karl, A, Schaefer, M, Malta, LS, Dorfel, D, Rohleder, N Werner, A (2006) A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev 30, 10041031.
115. Wang, Z, Neylan, TC, Mueller, SG, Lenoci, M, Truran, D, Marmar, CR, Weiner, MW Schuff, N (2010) Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder. Arch Gen Psychiatry 67, 296303.
116. Goldman, MB Mitchell, CP (2004) What is the functional significance of hippocampal pathology in schizophrenia? Schizophr Bull 30, 367392.
117. Revest, JM, Dupret, D, Koehl, M, Funk-Reiter, C, Grosjean, N, Piazza, PV Abrous, DN (2009) Adult hippocampal neurogenesis is involved in anxiety-related behaviors. Mol Psychiatry 14, 959967.
118. Snyder, JS, Soumier, A, Brewer, M, Pickel, J Cameron, HA (2011) Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 476, 458461.
119. Santarelli, L, Saxe, M, Gross, C, Surget, A, Battaglia, F, Dulawa, S, Weisstaub, N, Lee, J, Duman, R, Arancio, O, Belzung, C Hen, R (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805809.
120. Malberg, JE (2004) Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci 29, 196205.
121. Kempermann, G, Fabel, K, Ehninger, D, Babu, H, Leal-Galicia, P, Garthe, A Wolf, SA (2010) Why and how physical activity promotes experience-induced brain plasticity. Front Neurosci 4, 189.
122. Erickson, KI, Voss, MW, Prakash, RS, Basak, C, Szabo, A, Chaddock, L, Kim, JS, Heo, S, Alves, H, White, SM, Wojcicki, TR, Mailey, E, Vieira, VJ, Martin, SA, Pence, BD, Woods, JA, McAuley, E Kramer, AF (2011) Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A 108, 30173022.
123. Boldrini, M, Underwood, MD, Hen, R, Rosoklija, GB, Dwork, AJ, John Mann, J Arango, V (2009) Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34, 23762389.
124. Reif, A, Fritzen, S, Finger, M, Strobel, A, Lauer, M, Schmitt, A Lesch, KP (2006) Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 11, 514522.
125. Willner, P (2017) The chronic mild stress (CMS) model of depression: history, evaluation and usage. Neurobiol Stress 6, 7893.
126. Li, YF, Chen, HX, Liu, Y, Zhang, YZ, Liu, YQ Li, J (2006) Agmatine increases proliferation of cultured hippocampal progenitor cells and hippocampal neurogenesis in chronically stressed mice. Acta Pharmacol Sin 27, 13951400.
127. Li, B, Yamamori, H, Tatebayashi, Y, Shafit-Zagardo, B, Tanimukai, H, Chen, S, Iqbal, K Grundke-Iqbal, I (2008) Failure of neuronal maturation in Alzheimer disease dentate gyrus. J Neuropathol Exp Neurol 67, 7884.
128. Zhang, Z, Wang, W, Zhong, P, Liu, SJ, Long, JZ, Zhao, L, Gao, HQ, Cravatt, BF Liu, QS (2015) Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity. Hippocampus 25, 1626.
129. Schiavon, AP, Bonato, JM, Milani, H, Guimaraes, FS Weffort de Oliveira, RM (2016) Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice. Prog Neuropsychopharmacol Biol Psychiatry 64, 2734.
130. Hill, MN Gorzalka, BB (2005) Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? Behav Pharmacol 16, 333352.
131. Garcia-Gutierrez, MS, Perez-Ortiz, JM, Gutierrez-Adan, A Manzanares, J (2010) Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. Br J Pharmacol 160, 17731784.
132. Alzheimer’s, A (2016) 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 12, 459509.
133. Murray, RM Lewis, SW (1987) Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) 295, 681682.
134. Weinberger, DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44, 660669.
135. Garey, L (2010) When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits. J Anat 217, 324333.
136. Wu, CS, Jew, CP Lu, HC (2011) Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Future Neurol 6, 459480.
137. Richardson, KA, Hester, AK McLemore, GL (2016) Prenatal cannabis exposure – the ‘first hit’ to the endocannabinoid system. Neurotoxicol Teratol 58, 514.
138. Fried, PA (2002) Conceptual issues in behavioral teratology and their application in determining long-term sequelae of prenatal marihuana exposure. J Child Psychol Psychiatry 43, 81102.
139. Hall, W Degenhardt, L (2009) Adverse health effects of non-medical cannabis use. Lancet 374, 13831391.
140. El Marroun, H, Hudziak, JJ, Tiemeier, H, Creemers, H, Steegers, EA, Jaddoe, VW, Hofman, A, Verhulst, FC, van den Brink, W Huizink, AC (2011) Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend 118, 470474.
141. Tortoriello, G, Morris, CV, Alpar, A, Fuzik, J, Shirran, SL, Calvigioni, D, Keimpema, E, Botting, CH, Reinecke, K, Herdegen, T, Courtney, M, Hurd, YL Harkany, T (2014) Miswiring the brain: Delta9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway. EMBO J 33, 668685.
142. Sun, J, Fang, YQ, Ren, H, Chen, T, Guo, JJ, Yan, J, Song, S, Zhang, LY Liao, H (2013) WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats. Acta Pharmacol Sin 34, 119128.
143. de Salas-Quiroga, A, Diaz-Alonso, J, Garcia-Rincon, D, Remmers, F, Vega, D, Gomez-Canas, M, Lutz, B, Guzman, M Galve-Roperh, I (2015) Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons. Proc Natl Acad Sci U S A 112, 1369313698.
144. Barbeau, D, Liang, JJ, Robitalille, Y, Quirion, R Srivastava, LK (1995) Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U S A 92, 27852789.
145. Allen, KM, Fung, SJ Weickert, CS (2016) Cell proliferation is reduced in the hippocampus in schizophrenia. Aust N Z J Psychiatry 50, 473480.
146. Walton, NM, Zhou, Y, Kogan, JH, Shin, R, Webster, M, Gross, AK, Heusner, CL, Chen, Q, Miyake, S, Tajinda, K, Tamura, K, Miyakawa, T Matsumoto, M (2012) Detection of an immature dentate gyrus feature in human schizophrenia/bipolar patients. Transl Psychiatry 2, e135.
147. Maekawa, M, Takashima, N, Matsumata, M, Ikegami, S, Kontani, M, Hara, Y, Kawashima, H, Owada, Y, Kiso, Y, Yoshikawa, T, Inokuchi, K Osumi, N (2009) Arachidonic acid drives postnatal neurogenesis and elicits a beneficial effect on prepulse inhibition, a biological trait of psychiatric illnesses. PLoS One 4, e5085.
148. Chen, Q, Kogan, JH, Gross, AK, Zhou, Y, Walton, NM, Shin, R, Heusner, CL, Miyake, S, Tajinda, K, Tamura, K Matsumoto, M (2012) SREB2/GPR85, a schizophrenia risk factor, negatively regulates hippocampal adult neurogenesis and neurogenesis-dependent learning and memory. Eur J Neurosci 36, 25972608.
149. Iwata, Y, Suzuki, K, Wakuda, T, Seki, N, Thanseem, I, Matsuzaki, H, Mamiya, T, Ueki, T, Mikawa, S, Sasaki, T, Suda, S, Yamamoto, S, Tsuchiya, KJ, Sugihara, G, Nakamura, K, Sato, K, Takei, N, Hashimoto, K Mori, N (2008) Irradiation in adulthood as a new model of schizophrenia. PLoS One 3, e2283.
150. Nelson, MD, Saykin, AJ, Flashman, LA Riordan, HJ (1998) Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 55, 433440.
151. Dhikav, V Anand, KS (2007) Is hippocampal atrophy a future drug target? Med Hypotheses 68, 13001306.
152. Steen, RG, Mull, C, McClure, R, Hamer, RM Lieberman, JA (2006) Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188, 510518.
153. Ganzola, R, Maziade, M Duchesne, S (2014) Hippocampus and amygdala volumes in children and young adults at high-risk of schizophrenia: research synthesis. Schizophr Res 156, 7686.
154. Newton, SS Duman, RS (2007) Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. CNS Drugs 21, 715725.
155. Balu, DT Lucki, I (2009) Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology. Neurosci Biobehav Rev 33, 232252.
156. Meltzer, HY Sumiyoshi, T (2008) Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? Behav Brain Res 195, 98102.
157. Eisch, AJ, Barrot, M, Schad, CA, Self, DW Nestler, EJ (2000) Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci U S A 97, 75797584.
158. Malberg, JE, Eisch, AJ, Nestler, EJ Duman, RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20, 91049110.
159. Benninghoff, J, Grunze, H, Schindler, C, Genius, J, Schloesser, RJ, van der Ven, A, Dehning, S, Wiltfang, J, Moller, HJ Rujescu, D (2013) Ziprasidone--not haloperidol--induces more de-novo neurogenesis of adult neural stem cells derived from murine hippocampus. Pharmacopsychiatry 46, 1015.
160. Wakade, CG, Mahadik, SP, Waller, JL Chiu, FC (2002) Atypical neuroleptics stimulate neurogenesis in adult rat brain. J Neurosci Res 69, 7279.
161. Halim, ND, Weickert, CS, McClintock, BW, Weinberger, DR Lipska, BK (2004) Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 29, 10631069.
162. Peng, Z, Zhang, R, Wang, H, Chen, Y, Xue, F, Wang, L, Yang, F, Chen, Y, Liu, L, Kuang, F Tan, Q (2013) Ziprasidone ameliorates anxiety-like behaviors in a rat model of PTSD and up-regulates neurogenesis in the hippocampus and hippocampus-derived neural stem cells. Behav Brain Res 244, 18.
163. Kodama, M, Fujioka, T Duman, RS (2004) Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 56, 570580.
164. Fakhoury, M (2017) Role of the endocannabinoid system in the pathophysiology of schizophrenia. Mol Neurobiol 54, 768778.
165. Hajos, M, Hoffmann, WE Kocsis, B (2008) Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry 63, 10751083.
166. Stefanis, NC, Delespaul, P, Henquet, C, Bakoula, C, Stefanis, CN Van Os, J (2004) Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 99, 13331341.
167. Ujike, H, Takaki, M, Nakata, K, Tanaka, Y, Takeda, T, Kodama, M, Fujiwara, Y, Sakai, A Kuroda, S (2002) CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol Psychiatry 7, 515518.
168. De Marchi, N, De Petrocellis, L, Orlando, P, Daniele, F, Fezza, F Di Marzo, V (2003) Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis 2, 5.
169. Martinez-Gras, I, Hoenicka, J, Ponce, G, Rodriguez-Jimenez, R, Jimenez-Arriero, MA, Perez-Hernandez, E, Ampuero, I, Ramos-Atance, JA, Palomo, T Rubio, G (2006) (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population. Eur Arch Psychiatry Clin Neurosci 256, 437441.
170. Bortolato, M, Bini, V, Frau, R, Devoto, P, Pardu, A, Fan, Y Solbrig, MV (2014) Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats. Eur Neuropsychopharmacol 24, 974985.
171. Martinez-Orgado, J, Fernandez-Lopez, D, Lizasoain, I Romero, J (2007) The seek of neuroprotection: introducing cannabinoids. Recent Pat CNS Drug Discov 2, 131139.
172. Ritz, K, van Buchem, MA Daemen, MJ (2013) The heart-brain connection: mechanistic insights and models. Neth Heart J 21, 5557.
173. Dirnagl, U (2012) Pathobiology of injury after stroke: the neurovascular unit and beyond. Ann N Y Acad Sci 1268, 2125.
174. Arvidsson, A, Collin, T, Kirik, D, Kokaia, Z Lindvall, O (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8, 963970.
175. Heurteaux, C, Widmann, C, Moha ou Maati, H, Quintard, H, Gandin, C, Borsotto, M, Veyssiere, J, Onteniente, B Lazdunski, M (2013) NeuroAiD: properties for neuroprotection and neurorepair. Cerebrovasc Dis 35(Suppl. 1):17.
176. Wiltrout, C, Lang, B, Yan, Y, Dempsey, RJ Vemuganti, R (2007) Repairing brain after stroke: a review on post-ischemic neurogenesis. Neurochem Int 50, 10281041.
177. Pu, H, Jiang, X, Hu, X, Xia, J, Hong, D, Zhang, W, Gao, Y, Chen, J Shi, Y (2016) Delayed docosahexaenoic acid treatment combined with dietary supplementation of omega-3 fatty acids promotes long-term neurovascular restoration after ischemic stroke. Transl Stroke Res 7, 521534.
178. Mori, MA, Meyer, E, Soares, LM, Milani, H, Guimaraes, FS de Oliveira, RM (2017) Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia. Prog Neuropsychopharmacol Biol Psychiatry 75, 94105.
179. Han, H, Wu, LM, Han, MX, Yang, WM, Wang, YX Fang, ZH (2016) Diabetes impairs spatial learning and memory and hippocampal neurogenesis via BDNF in rats with transient global ischemia. Brain Res Bull 124, 269277.
180. Nagayama, T, Sinor, AD, Simon, RP, Chen, J, Graham, SH, Jin, K Greenberg, DA (1999) Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19, 29872995.
181. Fernandez-Lopez, D, Pradillo, JM, Garcia-Yebenes, I, Martinez-Orgado, JA, Moro, MA Lizasoain, I (2010) The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia. Stroke 41, 29562964.
182. Caltana, L, Saez, TM, Aronne, MP Brusco, A (2015) Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice. J Neurochem 135, 616629.
183. Fernandez-Lopez, D, Martinez-Orgado, J, Nunez, E, Romero, J, Lorenzo, P, Moro, MA Lizasoain, I (2006) Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats. Pediatr Res 60, 169173.
184. Bravo-Ferrer, I, Cuartero, MI, Zarruk, JG, Pradillo, JM, Hurtado, O, Romera, VG, Diaz-Alonso, J, Garcia-Segura, JM, Guzman, M, Lizasoain, I, Galve-Roperh, I Moro, MA (2017) Cannabinoid type-2 receptor drives neurogenesis and improves functional outcome after stroke. Stroke 48, 204212.
185. Arevalo-Martin, A, Garcia-Ovejero, D, Gomez, O, Rubio-Araiz, A, Navarro-Galve, B, Guaza, C, Molina-Holgado, E Molina-Holgado, F (2008) CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies. Br J Pharmacol 153, 216225.
186. Gale, SA, Acar, D Daffner, KR (2018) Dementia. Am J Med. Epub ahead of print.
187. Gotz, J Ittner, LM (2008) Animal models of Alzheimer’s disease and frontotemporal dementia. Nat Rev Neurosci 9, 532544.
188. Dorszewska, J, Prendecki, M, Oczkowska, A, Dezor, M Kozubski, W (2016) Molecular basis of familial and sporadic Alzheimer’s disease. Curr Alzheimer Res 13, 952963.
189. Sperling, R, Mormino, E Johnson, K (2014) The evolution of preclinical Alzheimer’s disease: implications for prevention trials. Neuron 84, 608622.
190. Dubois, B, Hampel, H, Feldman, HH, Scheltens, P, Aisen, P, Andrieu, S, Bakardjian, H, Benali, H, Bertram, L, Blennow, K, Broich, K, Cavedo, E, Crutch, S, Dartigues, JF, Duyckaerts, C, Epelbaum, S, Frisoni, GB, Gauthier, S, Genthon, R, Gouw, AA, Habert, MO, Holtzman, DM, Kivipelto, M, Lista, S, Molinuevo, JL, O’Bryant, SE, Rabinovici, GD, Rowe, C, Salloway, S, Schneider, LS, Sperling, R, Teichmann, M, Carrillo, MC, Cummings, J Jack, CR Jr., Proceedings of the Meeting of the International Working G, the American Alzheimer’s Association on “The Preclinical State of AD”, July, & Washington DC USA (2016) Preclinical Alzheimer’s disease: definition, natural history, and diagnostic criteria. Alzheimers Dement 12, 292323.
191. Mi, K Johnson, GV (2006) The role of tau phosphorylation in the pathogenesis of Alzheimer’s disease. Curr Alzheimer Res 3, 449463.
192. Schliebs, R Arendt, T (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease. J Neural Transm (Vienna) 113, 16251644.
193. Mann, DM (1996) Pyramidal nerve cell loss in Alzheimer’s disease. Neurodegeneration 5, 423427.
194. Raskin, J, Cummings, J, Hardy, J, Schuh, K Dean, RA (2015) Neurobiology of Alzheimer’s disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions. Curr Alzheimer Res 12, 712722.
195. Radad, K, Moldzio, R, Al-Shraim, M, Kranner, B, Krewenka, C Rausch, WD (2017) Recent advances on the role of neurogenesis in the adult brain: therapeutic potential in Parkinson’s and Alzheimer’s diseases. CNS Neurol Disord Drug Targets 16, 740748.
196. Crews, L, Adame, A, Patrick, C, Delaney, A, Pham, E, Rockenstein, E, Hansen, L Masliah, E (2010) Increased BMP6 levels in the brains of Alzheimer’s disease patients and APP transgenic mice are accompanied by impaired neurogenesis. J Neurosci 30, 1225212262.
197. Jin, K, Peel, AL, Mao, XO, Xie, L, Cottrell, BA, Henshall, DC Greenberg, DA (2004) Increased hippocampal neurogenesis in Alzheimer’s disease. Proc Natl Acad Sci U S A 101, 343347.
198. Perry, EK, Johnson, M, Ekonomou, A, Perry, RH, Ballard, C Attems, J (2012) Neurogenic abnormalities in Alzheimer’s disease differ between stages of neurogenesis and are partly related to cholinergic pathology. Neurobiol Dis 47, 155162.
199. Boekhoorn, K, Joels, M Lucassen, PJ (2006) Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol Dis 24, 114.
200. Bilkei-Gorzo, A (2014) Genetic mouse models of brain ageing and Alzheimer’s disease. Pharmacol Ther 142, 244257.
201. Marlatt, MW Lucassen, PJ (2010) Neurogenesis and Alzheimer’s disease: biology and pathophysiology in mice and men. Curr Alzheimer Res 7, 113125.
202. Kalifa, S, Polston, EK, Allard, JS Manaye, KF (2011) Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe/PS1DeltaE9 double transgenic mice. Brain Res 1376, 94100.
203. Aso, E, Palomer, E, Juves, S, Maldonado, R, Munoz, FJ Ferrer, I (2012) CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AbetaPP/PS1 mice. J Alzheimers Dis 30, 439459.
204. Marchalant, Y, Baranger, K, Wenk, GL, Khrestchatisky, M Rivera, S (2012) Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? J Neuroinflammation 9, 10.
205. Ramirez, BG, Blazquez, C, Gomez del Pulgar, T, Guzman, M de Ceballos, ML (2005) Prevention of Alzheimer’s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25, 19041913.
206. Westlake, TM, Howlett, AC, Bonner, TI, Matsuda, LA Herkenham, M (1994) Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer’s brains. Neuroscience 63, 637652.
207. Benito, C, Nunez, E, Tolon, RM, Carrier, EJ, Rabano, A, Hillard, CJ Romero, J (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer’s disease brains. J Neurosci 23, 1113611141.
208. Lee, JH, Agacinski, G, Williams, JH, Wilcock, GK, Esiri, MM, Francis, PT, Wong, PT, Chen, CP Lai, MK (2010) Intact cannabinoid CB1 receptors in the Alzheimer’s disease cortex. Neurochem Int 57, 985989.
209. Mulder, J, Zilberter, M, Pasquare, SJ, Alpar, A, Schulte, G, Ferreira, SG, Kofalvi, A, Martin-Moreno, AM, Keimpema, E, Tanila, H, Watanabe, M, Mackie, K, Hortobagyi, T, de Ceballos, ML Harkany, T (2011) Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease. Brain 134, 10411060.
210. Ahmad, R, Goffin, K, Van den Stock, J, De Winter, FL, Cleeren, E, Bormans, G, Tournoy, J, Persoons, P, Van Laere, K Vandenbulcke, M (2014) In vivo type 1 cannabinoid receptor availability in Alzheimer’s disease. Eur Neuropsychopharmacol 24, 242250.
211. Bedse, G, Romano, A, Cianci, S, Lavecchia, AM, Lorenzo, P, Elphick, MR, Laferla, FM, Vendemiale, G, Grillo, C, Altieri, F, Cassano, T Gaetani, S (2014) Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer’s disease. J Alzheimers Dis 40, 701712.
212. Maccarrone, M, Totaro, A, Leuti, A, Giacovazzo, G, Scipioni, L, Mango, D, Coccurello, R, Nistico, R Oddi, S (2018) Early alteration of distribution and activity of hippocampal type-1 cannabinoid receptor in Alzheimer’s disease-like mice overexpressing the human mutant amyloid precursor protein. Pharmacol Res. Epub ahead of print.
213. Solas, M, Francis, PT, Franco, R Ramirez, MJ (2013) CB2 receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients. Neurobiol Aging 34, 805808.
214. Savonenko, AV, Melnikova, T, Wang, Y, Ravert, H, Gao, Y, Koppel, J, Lee, D, Pletnikova, O, Cho, E, Sayyida, N, Hiatt, A, Troncoso, J, Davies, P, Dannals, RF, Pomper, MG Horti, AG (2015) Cannabinoid CB2 receptors in a mouse model of Abeta amyloidosis: immunohistochemical analysis and suitability as a PET biomarker of neuroinflammation. PLoS One 10, e0129618.
215. Aso, E, Andres-Benito, P Ferrer, I (2016) Delineating the efficacy of a Cannabis-based medicine at advanced stages of dementia in a murine model. J Alzheimers Dis 54, 903912.
216. Watt, G Karl, T (2017) In vivo evidence for therapeutic properties of cannabidiol (CBD) for Alzheimer’s disease. Front Pharmacol 8, 20.
217. Aso, E, Juves, S, Maldonado, R Ferrer, I (2013) CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AbetaPP/PS1 mice. J Alzheimers Dis 35, 847858.
218. Martin-Moreno, AM, Reigada, D, Ramirez, BG, Mechoulam, R, Innamorato, N, Cuadrado, A de Ceballos, ML (2011) Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer’s disease. Mol Pharmacol 79, 964973.
219. Esposito, G, Scuderi, C, Valenza, M, Togna, GI, Latina, V, De Filippis, D, Cipriano, M, Carratu, MR, Iuvone, T Steardo, L (2011) Cannabidiol reduces Abeta-induced neuroinflammation and promotes hippocampal neurogenesis through PPARgamma involvement. PLoS One 6, e28668.
220. Chen, B, Bromley-Brits, K, He, G, Cai, F, Zhang, X Song, W (2010) Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer’s disease mouse model. Curr Alzheimer Res 7, 255261.
221. Mandyam, CD Koob, GF (2012) The addicted brain craves new neurons: putative role for adult-born progenitors in promoting recovery. Trends Neurosci 35, 250260.


Type Description Title
Supplementary materials

de Oliveira et al. supplementary material
de Oliveira et al. supplementary material 1

 Word (26 KB)
26 KB

Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders

  • Rúbia W. de Oliveira (a1), Cilene L. Oliveira (a2), Francisco S. Guimarães (a3) (a4) and Alline C. Campos (a3) (a4)


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed